隐藏在眼前:招募的树突细胞是否围绕着阿尔茨海默病中的粉样斑块?
Robert B Nelson1, Kenneth N Rose2, Frank S Menniti1
1MindImmune Therapeutics, Inc., Kingston, RI; George and Anne Ryan Institute for Neuroscience, University of Rhode Island, Kingston, RI; Dept of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI.
Biochemical pharmacology
|May 5, 2024
概括
阿尔茨海默病 (AD) 病理学涉及大脑内天生的免疫细胞增加. 有证据表明,这些细胞是从骨髓中招募的,特别是髓状树突细胞,而不是转变的微质细胞.
科学领域:
- 神经免疫学 神经免疫学
- 阿尔茨海默氏症疾病的发病因子
- 天生的免疫系统研究研究
背景情况:
- 全基因组研究表明,在阿尔茨海默病 (AD) 发病过程中,先天免疫系统失调.
- 单细胞测序揭示了AD大脑中先天性免疫细胞亚型的增加,与AD病理和免疫相关风险有关.
- 一个普遍的假设表明这些细胞从居住的微质细胞转变,但其他理论提出骨髓起源.
研究的目的:
- 批判性地审查有关AD病理相关免疫细胞起源的翻译文献.
- 评估用于评估免疫细胞向大脑招募的技术和实验设计.
- 为了确定与阿尔茨海默氏症病原发生有关的免疫细胞的血统.
主要方法:
- 对几十年的翻译文献进行了全面的审查.
- 对用于研究免疫细胞招募的技术进行批判性分析.
- 在相关研究中对实验设计的评估.
主要成果:
- 总的证据支持在AD中将骨髓衍生的造血细胞招募到大脑中.
- 涉及的特定免疫细胞亚型属于髓状树突细胞系.
- 突出了当前技术和实验设计的局限性.
结论:
- 该研究得出结论,在阿尔茨海默病中,先天性免疫细胞,特别是髓状树突细胞,被招募到大脑中.
- 这一发现挑战了微质转化作为这些细胞的唯一来源的普遍观点.
- 树突细胞的招募对理解AD病因学和开发向治疗方法具有重要意义.
相关概念视频
Alzheimer's Disease: Overview
467
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
467
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K


